Changchun BCHT Biotechnology Management
Management criteria checks 2/4
Changchun BCHT Biotechnology's CEO is Wei Kong, appointed in Jan 2004, has a tenure of 5.92 years. directly owns 25.25% of the company’s shares, worth CN¥2.47B. The average tenure of the management team and the board of directors is 5.9 years and 4.8 years respectively.
Key information
Wei Kong
Chief executive officer
CN¥4.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 21yrs |
| CEO ownership | 25.2% |
| Management average tenure | 5.9yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO
Wei Kong (59 yo)
21yrs
Tenure
CN¥4,195,400
Compensation
Mr. Kong Wei serves as General Manager at Changchun BCHT Biotechnology Co. from 2004 and has been its Director from February 21, 2019.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 21yrs | CN¥4.20m | 25.25% CN¥ 2.5b | |
| Chief Financial Officer | 5.9yrs | CN¥2.13m | 0.0080% CN¥ 781.0k | |
| Executive Deputy GM & Director | no data | CN¥3.39m | 0.31% CN¥ 30.3m | |
| Board Secretary | 2.3yrs | CN¥1.42m | 0.0036% CN¥ 355.3k | |
| Deputy General Manager | 5.9yrs | CN¥3.47m | 0.24% CN¥ 23.7m | |
| Deputy General Manager | no data | CN¥2.72m | 0.17% CN¥ 17.1m | |
| Chief Operating Specialist | no data | no data | no data | |
| Deputy General Manager | 5.9yrs | CN¥801.80k | 0.27% CN¥ 26.9m | |
| Core Technical Staff | no data | no data | no data |
5.9yrs
Average Tenure
53yo
Average Age
Experienced Management: 688276's management team is seasoned and experienced (5.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 5.9yrs | CN¥4.20m | 25.25% CN¥ 2.5b | |
| Executive Deputy GM & Director | 4.8yrs | CN¥3.39m | 0.31% CN¥ 30.3m | |
| Independent Director | 4.6yrs | CN¥72.00k | no data | |
| Director | 5.9yrs | no data | no data | |
| Supervisor | 5.9yrs | no data | no data | |
| Director | 3.4yrs | no data | no data | |
| Chairman | 5.9yrs | no data | no data | |
| Director | 5.9yrs | no data | no data | |
| Independent Director | 4.6yrs | CN¥72.00k | no data | |
| Independent Director | 4.6yrs | CN¥72.00k | no data | |
| Chairman of the Supervisory Board | 4.8yrs | no data | 0.39% CN¥ 38.1m | |
| Employee Supervisor | 4.6yrs | no data | no data |
4.8yrs
Average Tenure
58.5yo
Average Age
Experienced Board: 688276's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/06 14:09 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Changchun BCHT Biotechnology Co. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hangci Zheng | China International Capital Corporation Limited |
| Yizheng Yang | China International Capital Corporation Limited |
| Sophia Zhang | China Stock Investment Research Co. Ltd. (GZ500..com) |